Published August 17, 2026 The Law Takes Effect November 12. Square’s Shutoff Starts November 5. That Gap Is the Whole Story. For months, the hemp industry’s entire clock has been set to one date: November 12, 2026, when a new federal definition threatens to wipe out most hemp cannabinoid products. Every strategy, every lobbying push,Continue reading “Square Just Cut Off Hemp Sellers — and Exposed the Ban That Arrives Before the Ban”
Category Archives: CBD & Hemp
Explore in-depth coverage of CBD, hemp regulation, and the evolving market for hemp-derived cannabinoid products. This section tracks policy changes, product innovation, and industry trends affecting CBD, Delta-8, hemp-derived THC, and other cannabinoids produced from federally legal hemp.
As lawmakers refine testing standards, licensing requirements, and product safety rules, CBD & Hemp coverage examines how regulatory shifts influence manufacturers, retailers, and consumers. From compliance changes and labeling standards to emerging product categories and wellness market expansion, this section analyzes how hemp continues evolving within the broader cannabis economy.
What This Category Covers
Within CBD & Hemp, readers will find reporting and analysis on topics such as:
Federal and state hemp regulatory updates
CBD product compliance and testing standards
Hemp-derived THC and minor cannabinoid developments
Consumer safety and labeling requirements
Market growth trends and retail expansion
Industry responses to shifting enforcement priorities
As hemp-derived cannabinoids become more integrated into mainstream retail and wellness markets, this category provides insight into the policies, products, and industry forces shaping the sector’s future.
Latest CBD & Hemp News
↓
Hemp Just Got a One-Month Reprieve. Here’s What That Month Is Actually For — and Why It May Not Be Enough.
Published August 4, 2026 A “Landmark Victory” That Buys 29 Days For months, the entire hemp industry has been bracing for November 12 — the day a new federal definition would wipe out an estimated 95% of hemp cannabinoid products. This past weekend, the industry got its first real reprieve. And the reaction was jubilant:Continue reading “Hemp Just Got a One-Month Reprieve. Here’s What That Month Is Actually For — and Why It May Not Be Enough.”
While Everyone Watches Congress, the States Are Quietly Building the Hemp Rules That Will Actually Govern Your Products
Published July 31, 2026 The Real Regulatory Action Isn’t in Washington. It’s in Albany, Denver, and a Dozen State Capitals. Every conversation about hemp right now points at one place: Congress, and the November 12 federal deadline. Will lawmakers delay it? Replace it? Let it hit? We’ve covered that fight extensively, and it matters. ButContinue reading “While Everyone Watches Congress, the States Are Quietly Building the Hemp Rules That Will Actually Govern Your Products”
Idaho’s Hemp Acreage Just Collapsed 81% — but Not for the Reason You’d Think
Published July 26, 2026 A Hemp Story With No Villain, No Ban, and a Lesson the Whole Industry Keeps Ignoring Here’s a hemp headline that has nothing to do with November 12. Idaho farmers will plant just 233 acres of hemp in 2026 — an 81% collapse from the year before, and the state’s lowestContinue reading “Idaho’s Hemp Acreage Just Collapsed 81% — but Not for the Reason You’d Think”
Two Words Decide Which Hemp Products Survive November: “Per Container”
Published July 19, 2026 The Whole Fight Comes Down to a Measurement Choice Almost everything written about the November hemp ban focuses on a number: 0.4 milligrams of THC. But the number isn’t what makes the ban so devastating. Two words next to it do all the work — “per container.” Change those two wordsContinue reading “Two Words Decide Which Hemp Products Survive November: “Per Container””
The Hemp Ban Has a Missing Instruction Manual — and the FDA Is Five Months Past Deadline to Write It
Published July 15, 2026 A Law Set to Outlaw a $28 Billion Industry Still Doesn’t Define Its Most Important Word We’ve written a lot about November 12 — the day the federal hemp redefinition takes effect and, by industry estimates, wipes out roughly 95% of the hemp cannabinoid market. Every countdown article, including ours, treatsContinue reading “The Hemp Ban Has a Missing Instruction Manual — and the FDA Is Five Months Past Deadline to Write It”
Medicare’s New CBD Program Is Real — But Almost Everything You’ve Heard About It Is Slightly Wrong
Published July 11, 2026 Yes, There’s a Federal Hemp Program Inside Medicare. No, Medicare Isn’t Paying for Your Gummies. Buried in the noise of this year’s cannabis policy avalanche is a program that would have been unthinkable five years ago: since April 1, doctors inside certain Medicare programs have been allowed to furnish hemp-derived CBDContinue reading “Medicare’s New CBD Program Is Real — But Almost Everything You’ve Heard About It Is Slightly Wrong”
Scientists Just Turned CBD Into Plastic — and It Might Replace Your Water Bottle
Published May 7, 2026 The Most Interesting Thing Happening in Hemp Right Now Isn’t in a Tincture Bottle While the CBD world sweats out the November hemp ban, a group of American researchers quietly published something that could matter far more in the long run: they turned cannabidiol into a high-performance plastic. The new material,Continue reading “Scientists Just Turned CBD Into Plastic — and It Might Replace Your Water Bottle”
The Hemp Ban Countdown: What Actually Becomes Illegal on November 12
Published July 3, 2026 The Clock Is Running on the Biggest Shakeup in Hemp Since 2018 Mark the date: November 12, 2026. That’s when a new federal definition of hemp takes effect. And unless Congress acts before then, it will outlaw the vast majority of hemp-derived products sold in America today. This isn’t a fringeContinue reading “The Hemp Ban Countdown: What Actually Becomes Illegal on November 12”
Medicare and Medicaid Launch Pilot Program Covering Certain Hemp-Derived CBD Products
Published June 29, 2026 A New Federal Pilot Program Is Bringing CBD Into the Healthcare Conversation One of the most significant hemp-related developments of 2026 isn’t coming from a state legislature or a cannabis company—it’s coming from the federal healthcare system. The Centers for Medicare & Medicaid Services (CMS) has launched a pilot program thatContinue reading “Medicare and Medicaid Launch Pilot Program Covering Certain Hemp-Derived CBD Products”